Fairhaven Wealth Management LLC boosted its holdings in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 0.7% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 10,097 shares of the healthcare conglomerate’s stock after buying an additional 72 shares during the period. UnitedHealth Group makes up about 1.6% of Fairhaven Wealth Management LLC’s investment portfolio, making the stock its 15th largest position. Fairhaven Wealth Management LLC’s holdings in UnitedHealth Group were worth $5,108,000 as of its most recent SEC filing.
Several other institutional investors also recently bought and sold shares of the business. Jmac Enterprises LLC increased its holdings in UnitedHealth Group by 2.2% in the 3rd quarter. Jmac Enterprises LLC now owns 823 shares of the healthcare conglomerate’s stock valued at $481,000 after purchasing an additional 18 shares in the last quarter. Wallace Capital Management Inc. grew its stake in shares of UnitedHealth Group by 0.9% in the third quarter. Wallace Capital Management Inc. now owns 2,119 shares of the healthcare conglomerate’s stock valued at $1,239,000 after buying an additional 19 shares in the last quarter. Western Pacific Wealth Management LP lifted its position in UnitedHealth Group by 2.2% during the 4th quarter. Western Pacific Wealth Management LP now owns 902 shares of the healthcare conglomerate’s stock worth $456,000 after acquiring an additional 19 shares in the last quarter. JNBA Financial Advisors grew its position in UnitedHealth Group by 0.4% in the third quarter. JNBA Financial Advisors now owns 4,686 shares of the healthcare conglomerate’s stock valued at $2,740,000 after acquiring an additional 20 shares in the last quarter. Finally, Paragon Capital Management LLC boosted its stake in shares of UnitedHealth Group by 2.9% in the third quarter. Paragon Capital Management LLC now owns 721 shares of the healthcare conglomerate’s stock valued at $422,000 after purchasing an additional 20 shares during the period. 87.86% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
A number of equities analysts have commented on UNH shares. Oppenheimer boosted their price objective on shares of UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a report on Friday, December 6th. Cantor Fitzgerald reissued an “overweight” rating and issued a $700.00 price target on shares of UnitedHealth Group in a report on Friday, January 17th. HSBC raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 target price on the stock in a research report on Friday, January 10th. Truist Financial cut their price target on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a report on Monday, January 6th. Finally, Hsbc Global Res raised shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research report on Friday, January 10th. One equities research analyst has rated the stock with a hold rating, twenty have given a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Buy” and an average price target of $629.32.
UnitedHealth Group Trading Down 1.1 %
Shares of UNH stock opened at $461.09 on Tuesday. The firm has a market capitalization of $424.33 billion, a PE ratio of 29.75, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The stock has a fifty day moving average of $518.52 and a two-hundred day moving average of $559.70.
UnitedHealth Group (NYSE:UNH – Get Free Report) last released its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating the consensus estimate of $6.74 by $0.07. The firm had revenue of $100.81 billion for the quarter, compared to analysts’ expectations of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. UnitedHealth Group’s quarterly revenue was up 6.8% on a year-over-year basis. During the same quarter last year, the company earned $5.83 EPS. As a group, research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.
UnitedHealth Group Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th will be issued a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 1.82%. UnitedHealth Group’s dividend payout ratio (DPR) is 54.19%.
Insider Buying and Selling
In other UnitedHealth Group news, Director Timothy Patrick Flynn purchased 1,000 shares of the firm’s stock in a transaction on Friday, January 17th. The shares were purchased at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the transaction, the director now owns 4,500 shares in the company, valued at $2,302,065. This represents a 28.57 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 0.33% of the stock is owned by corporate insiders.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Stories
- Five stocks we like better than UnitedHealth Group
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Finding Hidden Gems: Unconventional Penny Stock Investing
- Trading Stocks: RSI and Why it’s Useful
- Price Targets on NVIDIA Rise in Front of Earnings
- How to Short a Stock in 5 Easy StepsĀ
- Archer Aviation Stock Skids: Mistaking Progress for Bad News?
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.